Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
Where the cash went Twelve months to Sep 30, 2026
Free cash flow was −$27.2M: capital expenditures were more than operating cash flow. Cash rose by $857.0K. Lines the picture does not name came to +$12.9M. What is a cash flow statement?
- Free cash flow
- −$27.2M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- +$857.0K over the period
| Operating cash flow | −27.2 |
|---|---|
| Free cash flow | −27.2 |
| From investments, net | +15.1 |
| Other | +12.9 |
| Change in cash | 0.9 |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(26.66) | (26.06) | (15.44) | (18.21) |
+8 more TTM periods Free account |
Depreciation & Amortization |
(0.10) | (0.10) | (0.10) | (0.10) | |
Non Cash Items (Other) |
1.64 | 1.57 | (10.86) | (5.69) | |
Change in payables and accrued liability |
(3.04) | (1.15) | 3.78 | 0.92 | |
Change in other assets and liabilities |
1.02 | 0.72 | 0.96 | (0.41) | |
Operating Cash Flow |
(27.15) | (25.03) | (21.67) | (23.50) | |
Short Term Investments Change (Net) |
15.12 | 20.47 | 5.78 | (10.08) | |
Investing cash flow |
15.12 | 20.47 | 5.78 | (10.08) | |
Equity Repurchase (Common, Net) |
— | — | — | 0.53 | |
Other financial activities |
— | — | — | 22.17 | |
Financing cash flow |
— | — | — | 22.70 | |
Change in Cash |
0.86 | (4.88) | 8.41 | (10.88) | |
Beginning Cash |
20.73 | 20.73 | 20.73 | 31.61 | |
Ending Cash |
21.59 | 15.85 | 29.15 | 20.73 | |
Stock Based Compensation |
1.44 | 1.40 | 1.69 | 1.40 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(2.03) | (0.43) | 4.73 | 0.51 | |
Investments Change (Net) |
15.12 | 20.47 | 5.78 | (10.08) | |
Issuance/Purchase of Shares |
— | — | — | 0.53 |